A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection
Clicks: 386
ID: 114854
1991
In infants who require mechanical ventilation because of severe respiratory syncytial virus infection, treatment with aerosolized ribavirin decreases the duration of mechanical ventilation, oxygen treatment, and the hospital stay.
Reference Key |
dw1991thea
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Smith DW;Frankel LR;Mathers LH;Tang AT;Ariagno RL;Prober CG;; |
Journal | The New England journal of medicine |
Year | 1991 |
DOI | DOI not found |
URL | |
Keywords |
respiration
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
Mechanical
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
u.s. gov't
female
male
Infant
newborn
P.H.S.
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
length of stay
hospitalization / economics
c g prober
aerosols
ribavirin / administration & dosage*
respiratory syncytial viruses*
ribavirin / therapeutic use
respirovirus infections / therapy*
respirovirus infections / drug therapy
pmid:1904551
doi:10.1056/nejm199107043250105
d w smith
l r frankel
carbon dioxide / blood
oxygen / blood
partial pressure
artificial*
ventilators
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.